Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Ilson

Showing results (21-30 of 163) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2025
KEYNOTE-585 Fails While Matterhorn Succeeds in Gastric Cancer: What Lessons Can We Learn?David H Ilson
The Lancet. Oncology|June 24, 2014
Adjuvant treatment for gastric cancer: too much is not enoughDavid H Ilson
Surgical Oncology Clinics of North America|March 11, 2017
Current Progress in the Adjuvant Treatment of Gastric CancerDavid H Ilson
Cancer Investigation|December 8, 2004
Editorial on a phase I study on combined modality therapy in esophageal cancerDavid H Ilson
Gastrointestinal Cancer Research : GCR|June 8, 2013
Tenth Annual ISGIO MeetingDavid H Ilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?David H Ilson
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
Chemoradiotherapy in esophageal cancer: toxicity is in the eye of the beholderDavid H Ilson
Oncology (Williston Park, N.Y.)|December 15, 2010
Preoperative therapy in esophageal cancer: controversy and consensusDavid H Ilson
The Lancet. Gastroenterology & Hepatology|January 9, 2022
Emerging evidence for VEGF and immune checkpoint inhibition in oesophagogastric cancerDavid H Ilson
Current Opinion in Gastroenterology|October 11, 2018
Advances in the treatment of gastric cancerDavid H Ilson
Pageof 17

Showing results (21-30 of 163) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 19, 2025
KEYNOTE-585 Fails While Matterhorn Succeeds in Gastric Cancer: What Lessons Can We Learn?David H Ilson
The Lancet. Oncology|June 24, 2014
Adjuvant treatment for gastric cancer: too much is not enoughDavid H Ilson
Surgical Oncology Clinics of North America|March 11, 2017
Current Progress in the Adjuvant Treatment of Gastric CancerDavid H Ilson
Cancer Investigation|December 8, 2004
Editorial on a phase I study on combined modality therapy in esophageal cancerDavid H Ilson
Gastrointestinal Cancer Research : GCR|June 8, 2013
Tenth Annual ISGIO MeetingDavid H Ilson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2002
Epirubicin, cisplatin, and fluorouracil in gastric and esophageal cancer: a step ahead?David H Ilson
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 28, 2009
Chemoradiotherapy in esophageal cancer: toxicity is in the eye of the beholderDavid H Ilson
Oncology (Williston Park, N.Y.)|December 15, 2010
Preoperative therapy in esophageal cancer: controversy and consensusDavid H Ilson
The Lancet. Gastroenterology & Hepatology|January 9, 2022
Emerging evidence for VEGF and immune checkpoint inhibition in oesophagogastric cancerDavid H Ilson
Current Opinion in Gastroenterology|October 11, 2018
Advances in the treatment of gastric cancerDavid H Ilson
Pageof 17